Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462322000241
Abstract: Abstract In 2020, European Network for Health Technology Assessment (EUnetHTA) published a relative effectiveness analysis (REA) of Pretomanid in combination with Bedaquiline and Linezolid for the treatment of extensively drug-resistant (XDR) or treatment-intolerant or nonresponsive… read more here.
Keywords: assessment; outside europe; rea; effectiveness ... See more keywords